{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:43:45Z","timestamp":1793472225217,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN261201500003I"],"award-info":[{"award-number":["HHSN261201500003I"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jmb.2026.169985","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:18:55Z","timestamp":1786429135000},"page":"169985","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Allosteric Revolution: From Static Structures to Conformational Ensembles and Next-Generation Therapeutics"],"prefix":"10.1016","volume":"438","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8115-6415","authenticated-orcid":false,"given":"Ruth","family":"Nussinov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunbum","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2026.169985_b0005","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1017\/S0033583526100134","article-title":"Energy landscapes in molecular biology: history, principles, and perspectives","volume":"59","author":"Nussinov","year":"2026","journal-title":"Q. Rev. Biophys."},{"key":"10.1016\/j.jmb.2026.169985_b0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0022-2836(65)80285-6","article-title":"On the nature of allosteric transitions: a plausible model","volume":"12","author":"Monod","year":"1965","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2026.169985_b0015","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1021\/bi00865a047","article-title":"Comparison of experimental binding data and theoretical models in proteins containing subunits","volume":"5","author":"Koshland","year":"1966","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2026.169985_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.169044","article-title":"Pioneer in molecular biology: conformational ensembles in molecular recognition, allostery, and cell function","volume":"437","author":"Nussinov","year":"2025","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2026.169985_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004966","article-title":"Allostery: an overview of its history, concepts, methods, and applications","volume":"12","author":"Liu","year":"2016","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jmb.2026.169985_b0030","doi-asserted-by":"crossref","DOI":"10.1063\/5.0239162","article-title":"Introduction to new views of allostery","volume":"161","author":"Cui","year":"2024","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmb.2026.169985_b0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bpc.2013.09.003","article-title":"Essential role of conformational selection in ligand binding","volume":"186","author":"Vogt","year":"2014","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.jmb.2026.169985_b0040","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1021\/bi400929b","article-title":"Conformational selection is a dominant mechanism of ligand binding","volume":"52","author":"Vogt","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2026.169985_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102737","article-title":"Allosteric communication and signal transduction in proteins","volume":"84","author":"Wu","year":"2024","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jmb.2026.169985_b0050","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4880","article-title":"Molecular mechanisms of chaperone-directed protein folding: Insights from atomistic simulations","volume":"33","author":"Castelli","year":"2024","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmb.2026.169985_b0055","doi-asserted-by":"crossref","DOI":"10.1002\/pro.70543","article-title":"Ligand-driven modulation of chaperone-cochaperone networks shapes proteostasis outcomes","volume":"35","author":"Magni","year":"2026","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmb.2026.169985_b0060","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1021\/acs.jmedchem.4c02314","article-title":"Discovery of Daraxonrasib (RMC-6236), a potent and orally bioavailable RAS(ON) multi-selective, noncovalent tri-complex inhibitor for the treatment of patients with multiple RAS-addicted cancers","volume":"68","author":"Cregg","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2026.169985_b0065","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1529","article-title":"Rational design of allosteric modulators: challenges and successes","volume":"11","author":"Chatzigoulas","year":"2021","journal-title":"WIREs Comput. Mol. Sci."},{"key":"10.1016\/j.jmb.2026.169985_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2024.102774","article-title":"Machine learning approaches in predicting allosteric sites","volume":"85","author":"Nerin-Fonz","year":"2024","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jmb.2026.169985_b0075","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1021\/acsmedchemlett.4c00260","article-title":"Allostery illuminated: harnessing AI and machine learning for drug discovery","volume":"15","author":"Blanco","year":"2024","journal-title":"ACS Med. Chem. Letter"},{"key":"10.1016\/j.jmb.2026.169985_b0080","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.str.2025.07.021","article-title":"Design of multi-target peptide modulators for protein chaperone networks","volume":"33","author":"Torielli","year":"2025","journal-title":"Structure"},{"key":"10.1016\/j.jmb.2026.169985_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2026.108205","article-title":"Hijacking client instability to selectively disrupt HSP90-driven glucocorticoid receptor activation","volume":"228","author":"Longhi","year":"2026","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jmb.2026.169985_b0090","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1146\/annurev-biophys-050511-102319","article-title":"Structural and energetic basis of allostery","volume":"41","author":"Hilser","year":"2012","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.jmb.2026.169985_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.169537","article-title":"On the relationship between protein stability, thermostability, and allosteric signaling","volume":"438","author":"Raechell","year":"2026","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2026.169985_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.169293","article-title":"Designing structure-specific and switchable allosteric effectors for GPCRs based on the causality and energetics of inherent signaling","volume":"437","author":"Dong","year":"2025","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2026.169985_b0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1101\/SQB.1961.026.01.048","article-title":"Teleonomic mechanisms in cellular metabolism, growth, and differentiation","volume":"26","author":"Monod","year":"1961","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.jmb.2026.169985_b0110","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1126\/science.1749933","article-title":"The energy landscapes and motions of proteins","volume":"254","author":"Frauenfelder","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.jmb.2026.169985_b0115","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1039\/c4cp90027h","article-title":"A second molecular biology revolution? The energy landscapes of biomolecular function","volume":"16","author":"Nussinov","year":"2014","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.jmb.2026.169985_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102722","article-title":"Cell phenotypes can be predicted from propensities of protein conformations","volume":"83","author":"Nussinov","year":"2023","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jmb.2026.169985_b0125","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.1158818","article-title":"Biochemistry. How do proteins interact?","volume":"320","author":"Boehr","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.jmb.2026.169985_b0130","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nchembio.232","article-title":"The role of dynamic conformational ensembles in biomolecular recognition","volume":"5","author":"Boehr","year":"2009","journal-title":"Nature Chem. Biol."},{"key":"10.1016\/j.jmb.2026.169985_b0135","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2513851123","article-title":"Phosphatase SHP2 pathogenic mutations enhance activity by altering conformational sampling","volume":"123","author":"Glaser","year":"2026","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2026.169985_b0140","doi-asserted-by":"crossref","first-page":"6263","DOI":"10.1021\/acs.chemrev.6b00283","article-title":"Introduction to protein ensembles and allostery","volume":"116","author":"Nussinov","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jmb.2026.169985_b0145","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1021\/acs.chemrev.5b00562","article-title":"Protein ensembles: how does nature harness thermodynamic fluctuations for life? The diverse functional roles of conformational ensembles in the cell","volume":"116","author":"Wei","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jmb.2026.169985_b0150","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.tibs.2010.04.009","article-title":"Induced fit, conformational selection and independent dynamic segments: an extended view of binding events","volume":"35","author":"Csermely","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jmb.2026.169985_b0155","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tips.2022.03.011","article-title":"Sotorasib: a KRASG12C inhibitor for non-small cell lung cancer","volume":"43","author":"Ganguly","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jmb.2026.169985_b0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13046-021-02225-w","article-title":"The path to the clinic: a comprehensive review on direct KRASG12C inhibitors","volume":"41","author":"Kwan","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jmb.2026.169985_b0165","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.tips.2026.01.006","article-title":"Leveraging conformational ensembles in allosteric drug discovery","volume":"47","author":"Nussinov","year":"2026","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jmb.2026.169985_b0170","first-page":"171","article-title":"Molecular recognition by induced fit: how fit is the concept?","volume":"16","author":"Bosshard","year":"2001","journal-title":"News Physiol. Sci."},{"key":"10.1016\/j.jmb.2026.169985_b0175","doi-asserted-by":"crossref","first-page":"6180","DOI":"10.1021\/acs.jctc.6c00082","article-title":"Measuring differences in protein allosteric graphs constructed via molecular dynamics simulations","volume":"22","author":"Shi","year":"2026","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jmb.2026.169985_b0180","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1021\/acscentsci.8b00274","article-title":"Quantifying the intrinsic conformation energy landscape topography of proteins with large-scale open-closed transition","volume":"4","author":"Chu","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jmb.2026.169985_b0185","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65498","article-title":"Allosteric conformational ensembles have unlimited capacity for integrating information","volume":"10","author":"Biddle","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.jmb.2026.169985_b0190","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1017\/S0033583525100061","article-title":"Allostery: allosteric networks and allosteric signaling bias","volume":"58","author":"Nussinov","year":"2025","journal-title":"Q. Rev. Biophys."},{"key":"10.1016\/j.jmb.2026.169985_b0195","doi-asserted-by":"crossref","first-page":"9669","DOI":"10.1021\/acs.jctc.5c00935","article-title":"Machine learning navigated allosteric network to unveil biased allosteric modulation of GPCRs","volume":"21","author":"Kong","year":"2025","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jmb.2026.169985_b0200","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.cell.2016.08.015","article-title":"Allosteric modulation as a unifying mechanism for receptor function and regulation","volume":"166","author":"Changeux","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2026.169985_b0205","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1021\/acs.jmedchem.8b01749","article-title":"Allosteric modulator discovery: from serendipity to structure-based design","volume":"62","author":"Lu","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2026.169985_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2025.103172","article-title":"Allosteric solution to the problems of undruggable targets, drug toxicity, and emerging resistance","volume":"95","author":"Tee","year":"2025","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jmb.2026.169985_b0215","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.str.2023.04.007","article-title":"Structure-based prediction of Ras-effector binding affinities and design of \u201cbranchegetic\u201d interface mutations","volume":"31","author":"Junk","year":"2023","journal-title":"Structure"},{"key":"10.1016\/j.jmb.2026.169985_b0220","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.str.2013.06.002","article-title":"Allosteric conformational barcodes direct signaling in the cell","volume":"21","author":"Nussinov","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.jmb.2026.169985_b0225","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/cac2.12395","article-title":"Activation mechanisms of clinically distinct B-Raf V600E and V600K mutants","volume":"43","author":"Zhang","year":"2023","journal-title":"Cancer Commun. (Lond)"},{"key":"10.1016\/j.jmb.2026.169985_b0230","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1158\/1078-0432.CCR-18-1680","article-title":"Distinct molecular profiles and immunotherapy treatment outcomes of V600E and V600K BRAF-mutant melanoma","volume":"25","author":"Pires da Silva","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jmb.2026.169985_b0235","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adq6647","article-title":"Kras G12C- and G12D-driven lung cancers differ in oncogenic potency, immunogenicity, and relapse after Kras inhibition in mouse models","volume":"18","author":"Huang","year":"2026","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jmb.2026.169985_b0240","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2518125123","article-title":"Accurate conformational ensembles of intrinsically disordered proteins using reweighting based on NMR chemical shifts","volume":"123","author":"Jeon","year":"2026","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2026.169985_b0245","doi-asserted-by":"crossref","first-page":"10447","DOI":"10.1021\/acs.jmedchem.4c00935","article-title":"Fentanyl-type antagonist of the mu-opioid receptor: important role of axial chirality in the active conformation","volume":"67","author":"Arita","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2026.169985_b0250","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022112940","article-title":"Structural insights into angiotensin receptor signaling modulation by balanced and biased agonists","volume":"42","author":"Zhang","year":"2023","journal-title":"EMBO J."},{"key":"10.1016\/j.jmb.2026.169985_b0255","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bpj.2020.11.2262","article-title":"The biased ligands NGF and NT-3 differentially stabilize Trk-A dimers","volume":"120","author":"Ahmed","year":"2021","journal-title":"Biophys. J."},{"key":"10.1016\/j.jmb.2026.169985_b0260","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1038\/s41467-026-69437-6","article-title":"Positive cooperativity between RAS-binding and cysteine-rich domains regulates RAF membrane binding kinetics via lateral rebinding","volume":"17","author":"Jimenez Salinas","year":"2026","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2026.169985_b0265","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.str.2018.01.011","article-title":"Raf-1 cysteine-rich domain increases the affinity of K-Ras\/Raf at the membrane. Promoting MAPK signaling","volume":"26","author":"Li","year":"2018","journal-title":"Structure"},{"key":"10.1016\/j.jmb.2026.169985_b0270","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.cels.2024.01.009","article-title":"Widespread alteration of protein autoinhibition in human cancers","volume":"15","author":"Holguin-Cruz","year":"2024","journal-title":"Cell Syst."},{"key":"10.1016\/j.jmb.2026.169985_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2022.167569","article-title":"Allostery: allosteric cancer drivers and innovative allosteric drugs","volume":"434","author":"Nussinov","year":"2022","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2026.169985_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2024.102974","article-title":"Advances in structure-based allosteric drug design","volume":"90","author":"Li","year":"2025","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jmb.2026.169985_b0285","doi-asserted-by":"crossref","first-page":"24274","DOI":"10.1021\/jacs.6c05178","article-title":"Allosteric inhibition of PKMYT1 induces a unique, inactive ATP binding site conformation","volume":"148","author":"Herrington","year":"2026","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmb.2026.169985_b0290","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.chembiol.2025.03.006","article-title":"CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancers","volume":"32","author":"Kwiatkowski","year":"2025","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jmb.2026.169985_b0295","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41594-023-01182-6","article-title":"Dynamic molecular architecture and substrate recruitment of cullin3-RING E3 ligase CRL3(KBTBD2)","volume":"31","author":"Hu","year":"2024","journal-title":"Nature Struct. Mol. Biol."},{"key":"10.1016\/j.jmb.2026.169985_b0300","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/s41586-026-10129-y","article-title":"CSN5i-3 is an orthosteric molecular glue inhibitor of COP9 signalosome","volume":"652","author":"Shi","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2026.169985_b0305","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1021\/jacs.5c14840","article-title":"Allosteric PROTACs: expanding the horizon of targeted protein degradation","volume":"148","author":"Frost","year":"2026","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmb.2026.169985_b0310","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1021\/acs.jcim.6c00279","article-title":"Cyclin-E\/A\/CDK1\/2 kinetic landscapes drive cell cycle phase-specific progression and guide cyclin-E degradation strategy","volume":"66","author":"Zhang","year":"2026","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmb.2026.169985_b0315","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1080\/17460441.2024.2376655","article-title":"Inhibitors and PROTACs of CDK2: challenges and opportunities","volume":"19","author":"Zeng","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.jmb.2026.169985_b0320","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1158\/2159-8290.CD-23-0944","article-title":"Discovery and clinical proof-of-concept of RLY-2608, a first-in-class mutant-selective allosteric PI3Kalpha inhibitor that decouples antitumor activity from hyperinsulinemia","volume":"14","author":"Varkaris","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jmb.2026.169985_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104197","article-title":"Which cryptic sites are feasible drug targets?","volume":"29","author":"Lazou","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jmb.2026.169985_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102702","article-title":"Computing allostery: from the understanding of biomolecular regulation and the discovery of cryptic sites to molecular design","volume":"83","author":"Colombo","year":"2023","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jmb.2026.169985_b0335","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1021\/acs.jcim.4c02022","article-title":"mTOR variants activation discovers PI3K-like cryptic pocket, expanding allosteric, mutant-selective inhibitor designs","volume":"65","author":"Liu","year":"2025","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmb.2026.169985_b0340","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa2505783","article-title":"Daraxonrasib in previously treated advanced RAS-mutated pancreatic cancer","volume":"394","author":"Wolpin","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2026.169985_b0345","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1021\/acs.jpcb.2c04346","article-title":"AlphaFold, artificial intelligence (AI), and allostery","volume":"126","author":"Nussinov","year":"2022","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jmb.2026.169985_b0350","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nbt.2026.02.010","article-title":"Harnessing AI to decode protein kinases: structural, functional, and therapeutic design perspectives","volume":"93","author":"Gomari","year":"2026","journal-title":"N. Biotechnol."},{"key":"10.1016\/j.jmb.2026.169985_b0355","article-title":"Generative AI for drug discovery and protein design: the next frontier in AI-driven molecular science","volume":"27","author":"Das","year":"2025","journal-title":"Med Drug Discov."},{"key":"10.1016\/j.jmb.2026.169985_b0360","doi-asserted-by":"crossref","DOI":"10.1002\/minf.201700153","article-title":"De Novo design of bioactive small molecules by artificial intelligence","volume":"37","author":"Merk","year":"2018","journal-title":"Mol Inform."},{"key":"10.1016\/j.jmb.2026.169985_b0365","doi-asserted-by":"crossref","first-page":"16260","DOI":"10.1021\/acs.jmedchem.5c01173","article-title":"AI-driven discovery and optimization of positive allosteric modulators for NMDA receptors: potential applications in depression","volume":"68","author":"Yang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2026.169985_b0370","article-title":"Artificial allosteric protein switches with machine-learning-designed receptors","author":"Guo","year":"2026","journal-title":"Nature Biotechnol."},{"key":"10.1016\/j.jmb.2026.169985_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102758","article-title":"Allosteric drugs: new principles and design approaches","volume":"84","author":"Tee","year":"2024","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jmb.2026.169985_b0380","article-title":"Decoding the allosteric paradox: a dual framework integrating AI cofolding models with landscape-guided interpretable AI framework of ligand-protein binding","author":"Parikh","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.jmb.2026.169985_b0385","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1021\/acs.jcim.5c02227","article-title":"AI-guided conformational dynamics of p53 L1 loop reveal an allosteric switch regulating DNA binding and cancer hotspots","volume":"66","author":"Navarro Acero","year":"2026","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmb.2026.169985_b0390","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3390\/ph19030480","article-title":"AI-driven design of miniproteins as potential allosteric modulators","volume":"19","author":"Liu","year":"2026","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jmb.2026.169985_b0395","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41392-025-02129-7","article-title":"Molecular principles underlying aggressive cancers","volume":"10","author":"Nussinov","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jmb.2026.169985_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189328","article-title":"Tumors and their microenvironments: Learning from pediatric brain pathologies","volume":"1880","author":"Nussinov","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.jmb.2026.169985_b0405","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.sbi.2020.03.006","article-title":"Allostery in membrane proteins","volume":"62","author":"Cournia","year":"2020","journal-title":"Curr. Opin. Struct. Biol."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002228362600358X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002228362600358X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:28:35Z","timestamp":1790612915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002228362600358X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":81,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S002228362600358X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2026.169985","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Allosteric Revolution: From Static Structures to Conformational Ensembles and Next-Generation Therapeutics","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2026.169985","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"169985"}}